SHP2: a new target for pro-senescence cancer therapies.
Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Manuel
M
Serrano
D000818:Animals; D016922:Cellular Senescence; D005260:Female; D006801:Humans; D015674:Mammary Neoplasms, Animal / Q000201:enzymology*; D054592:Protein Tyrosine Phosphatase, Non-Receptor Type 11 / Q000378:metabolism*
D054592:Protein Tyrosine Phosphatase, Non-Receptor Type 11